Moore, K. T. and Langas, M. (2018) “Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the limits of our knowledge”, Journal of Cardiology and Cardiovascular Medicine, 3(3), pp. 049–051. doi: 10.29328/journal.jccm.1001026.